Prenatal exposure to valproic acid causes allodynia associated with spinal microglial activation.
Animals
Autism Spectrum Disorder
/ chemically induced
Calcium
Disease Models, Animal
Female
Humans
Hyperalgesia
/ chemically induced
Macrophage Colony-Stimulating Factor
/ antagonists & inhibitors
Male
Mice
Mice, Inbred ICR
Microglia
Pain
/ chemically induced
Pregnancy
Prenatal Exposure Delayed Effects
/ chemically induced
Saporins
Valproic Acid
/ toxicity
Allodynia
Autism spectrum disorder
Microglia
Spinal cord
Valproic acid
Journal
Neurochemistry international
ISSN: 1872-9754
Titre abrégé: Neurochem Int
Pays: England
ID NLM: 8006959
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
03
06
2022
revised:
14
08
2022
accepted:
19
08
2022
pubmed:
27
8
2022
medline:
14
10
2022
entrez:
26
8
2022
Statut:
ppublish
Résumé
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication and social interaction and the presence of restricted, repetitive behaviors. Additionally, difficulties in sensory processing commonly occur in ASD. Sensory abnormalities include heightened or reduced sensitivity to pain, but the mechanism underlying sensory phenotypes in ASD remain unknown. Emerging evidence suggests that microglia play an important role in forming and refining neuronal circuitry, and thus contribute to neuronal plasticity and nociceptive signaling. In the present study, we investigated the age-dependent tactile sensitivity in an animal model of ASD induced by prenatal exposure to valproic acid (VPA) and subsequently assessed the involvement of microglia in the spinal cord in pain processing. Pregnant ICR (CD1) mice were intraperitoneally injected with either saline or VPA (500 mg/kg) on embryonic day 12.5. Male offspring of VPA-treated mothers showed mechanical allodynia at both 4 and 8 weeks of age. In the spinal cord dorsal horn in prenatally VPA-treated mice, the numbers and staining intensities of ionized calcium-binding adapter molecule 1-positive cells were increased and the cell bodies became enlarged, indicating microglial activation. Treatment with PLX3397, a colony-stimulating factor 1 receptor inhibitor, for 10 days resulted in a decreased number of spinal microglia and attenuated mechanical allodynia in adult mice prenatally exposed to VPA. Additionally, intrathecal injection of Mac-1-saporin, a saporin-conjugated anti-CD11b antibody to deplete microglia, abolished mechanical allodynia. These findings suggest that prenatal VPA treatment causes allodynia and that spinal microglia contribute to the increased nociceptive responses.
Identifiants
pubmed: 36027995
pii: S0197-0186(22)00140-1
doi: 10.1016/j.neuint.2022.105415
pii:
doi:
Substances chimiques
Valproic Acid
614OI1Z5WI
Macrophage Colony-Stimulating Factor
81627-83-0
Saporins
EC 3.2.2.22
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105415Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no conflicts of interest.